Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 6—June 2016
CME ACTIVITY - Synopsis

Infectious Disease Risk Associated with Contaminated Propofol Anesthesia, 1989–20141

Andrés Zorrilla-VacaComments to Author , Jimmy J. Arevalo, Kevin Escandón-Vargas, Daniel Soltanifar, and Marek A. Mirski
Author affiliations: Universidad del Valle School of Medicine, Cali, Colombia (A. Zorrilla-Vaca, K. Escandón-Vargas); Fundación Universitaria de Ciencias de la Salud, Bogota, Colombia (J.J. Arevalo); Royal Free Hospital, London, United Kingdom (D. Soltanifar); Johns Hopkins University School of Medicine, Baltimore, Maryland, USA (M.A. Mirski)

Main Article

Table 4

Summary of epidemiologic studies analyzing the association between infectious conditions and contaminated propofol anesthesia*

Followed manufacturers’ precautions, study, year Type of study Preservative-free propofol† Other agents compared with propofol Type of infection Hospital unit‡ Association§
Yes
Seeberger et al., 1998 Retrospective cohort Yes Thiopentone Sepsis OR No
Shimizu et al., 2010 Cohort ND Sevoflurane SSI OR Yes
Haddad et al., 2011 Nested cohort Yes ND Multiple¶ ICU Yes
Moehring et al., 2014
Case–control
ND
Fentanyl
BSI
ICU
No
No
Bennett et al., 1995. (2) Case–control and cohort Yes Sufentanil, alfentanil BSI, SSI OR Yes
Henry et al., 2001 (4) Case–control Yes ND BSI, SSI OR Yes
McNeil et al., 1999 Cohort Yes Sufentanil, fentanyl, midazolam, vecuronium Fungemia, endophthalmitis OR Yes
Sebert et al., 2002. Case–control ND ND BSI OR No
Muller et al., 2010 (15)
Retrospective cohort
ND
Fentanyl, midazolam
BSI, SIRS
OR
Yes
ND
Kontopoulou et al., 2012
Case–control
ND
ND
BSI
ICU
Yes
*Complete data and full references are available in the Technical Appendix; OR, operating room; ICU, intensive care unit; BSI, bloodstream infection; SSI, Surgical site infection; ND, not described in publication; SIRS, systemic inflammatory response syndrome.
†Use of propofol without antimicrobial additives.
‡Hospital unit where the studies were conducted.
§Conclusion of the analytical study regarding the association between propofol exposure and infectious events.
¶Multiple infection types, including ventilator-associated pneumonia, urosepsis, BSI, catheter-related infections, and others.

Main Article

1Part of this work was presented at the XXXI Colombian Congress of Anesthesiology and Critical Care, Cali, Columbia, July 2015.

Page created: May 11, 2016
Page updated: May 11, 2016
Page reviewed: May 11, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external